ImmunologybioRxiv
mRNA based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus neutralizing antibodies and mediates protection in rodents
S. Rauch, N. Roth, K. Schwendt…·B. Petsch
This study shows that the mRNA vaccine CVnCoV induces strong neutralizing antibodies and protects hamsters from SARS-CoV-2 infection.
DOI 10.1038/s41541-021-00311-w